Marimed (MRMD) Change in Receivables (2014 - 2026)

Marimed (MRMD) has reported Change in Receivables for 13 consecutive years, with $629000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Receivables rose 139.21% year-over-year to $629000.0 in Q2 2026; TTM through Jun 2026 was $2.8 million, a 542.31% increase from a year earlier, with the FY2025 full-year figure at $429000.0, down 64.46% from the prior year.
• Change in Receivables was $629000.0 for Q2 2026 at Marimed, up from $401000.0 in the prior quarter.
• Over five years, Change in Receivables peaked at $2.0 million in Q4 2022 and troughed at -$1.6 million in Q2 2025.
• A 5-year average of $707111.1 and a median of $862000.0 in 2023 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables slumped 635.61% in 2024 and surged 160.85% in 2025, its largest moves.
• Over 5 years, Change in Receivables stood at $2.0 million in 2022, then tumbled by 46.48% to $1.1 million in 2023, then gained by 11.05% to $1.2 million in 2024, then gained by 15.3% to $1.4 million in 2025, then plunged by 55.14% to $629000.0 in 2026.
• The last three Change in Receivables figures came in at $629000.0 (Q2 2026), $401000.0 (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.